🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Proteins and AI have officially dominated the Nobels. What a time for society, this field is a 🚀. Enough of the noise about “is this just hype?” The only words that matter are — Let’s build. Well deserved for Hopfield, Hinton, Baker, Hassabis, and Jumper!

Legendary VC Bill Gurley on why “TAM conservatism” often hurts investors “I’ve found that TAM conservatism hurts you more than it helps you as an investor. If you feel like something is super disruptive and it’s unlocking things, your optionality to build on top of that is going

I’ll be in Vancouver for NeurIPS December 13-16, reach out if you’re interested in protein language models, genome editor / antibody design, or any of the other cool stuff we’re doing Profluent!

This is not the case for biology. A huge source of optimism for untapped and *uncapped* potential. Reach out if you want more details on what we’re witnessing

Kyunghyun Cho wrote a thoughtful note on the AI job market. I think he gets some important things right. Other things seem different from my perspective. My own stream of consciousness inspired by Kyunghyun Cho's essay and the broader discourse.

👀 “what this [AI] will do for the ability to deliver high quality healthcare, the costs, but really to CURE the diseases… I think will be among the most important things this technology [AI] does” — Sam Altman

Loved this interview by Errik Anderson. Just 20 years ago, every single person in biotech would tell you with a straight face that biologics will never be as big as small molecules - expensive, complicated, too many unknowns. And yet today: - Top 3 best selling drugs of 2024 are

Compact functional systems with immediate utility for genome and epigenome editing/modulation. All unique and generated by our AI platform. Message me with questions if interested in licensing!

Absolutely incredible. What a bright future and beacon for personalized medicine and gene editing. This field is incredibly inspiring. Congratulations to the amazing Kiran Musunuru Fyodor Urnov Ben Kleinstiver Sadik Kassim Rebecca Ahrens-Nicklas and full team